28/08/2021
Onderzoek toont aan dat we met flowventilatie goede resultaten laten zien in tegenstelling tot alles wat er tot nu toe toegepast wordt bij COVID
COVID-19 is such a crippling disease
If there is a known technology that has been proven to reduce the length of time in the ICU, and reduce intubations of COVID-19 patients, wouldn’t you want to use it and give your patients the best possible therapy?
Intrapulmonary Percussive Ventilation (IPV®) utilizing High-Frequency Percussive Ventilation technology (HFPV®) from Percussionaire Corporation has been proven to do just that.
Intermittent High-Frequency Percussive Ventilation Therapy in 3 Patients with Severe COVID-19 Pneumonia
Sergey P. Marchenko, et al e-ISSN 1941-5923 © Am J Case Rep, 2020; 21: e928421 DOI: 10.12659/AJCR.928421
Since the start of the pandemic, many hospitals have discovered how IPV therapy has reduced the time on high flow nasal oxygen, BiPAP and reduced intubations.
Proven, True IPV®, there is no substitute…